Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Institute of Medicinal Biotechnology
Auto-generated profile, based on publicly available information
Yuchuan Chen
Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Institute of Medicinal Biotechnology
In this paper, we present the discovery of a novel salicylic acid derivative, moldavica acid A (1), and a new natural dibenzo[b,f]oxepin, moldavica acid B (2), together with four known phenylpropionic acids (3-6) and protocatechuic acid (7) that were isolated from Dracocephalum moldavica L. Their structures were elucidated by comprehensive spectroscopic methods, including infrared and nuclear magnetic resonance. Compound 1 is the first example of salicylic acid linking a carboxylated α-pyrone via an ethyl bridge. Beyond expanding the knowledge of the chemical diversity of D. moldavica, both compounds 1 and 2 were shown to upregulate the expression of Kruppel-like factor 2, which could serve as a prospective therapeutic target for the treatment of atherosclerosis. Graphical Abstract
This paper presents a convolutional neural network (CNN) model, underpinned by deep learning principles, tailored to predict endovascular intervention outcomes in patients with acute anterior circulation ischemic stroke. Recognizing the crucial role of predictive models in guiding patient prognosis and treatment selection, we partitioned our dataset into training and testing subsets. The proposed CNN model exhibited outstanding performance during its training phase, reaching a stellar accuracy rate of 100%. This performance was maintained during the testing phase, with an accuracy surpassing 94.12%. Such minimal deviation between training and testing accuracies underscores the robustness of our model and suggests a reduced likelihood of overfitting, enhancing its relevance for real-world clinical scenarios. These promising results signify a leap forward in harnessing the power of deep learning for medical prognostication, particularly in stroke intervention outcomes.